{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:34:43Z","timestamp":1791520483820,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.tranon.2024.102179","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T17:04:11Z","timestamp":1730912651000},"page":"102179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Res@ZIF-90 suppress gastric cancer progression by disturbing mitochondrial homeostasis"],"prefix":"10.1016","volume":"51","author":[{"given":"Guanglin","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enmeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengke","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangning","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangming","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2210-6279","authenticated-orcid":false,"given":"Lin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.tranon.2024.102179_bib0001","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1002\/cam4.3892","article-title":"Chinese and global burdens of gastric cancer from 1990 to 2019","volume":"10","author":"He","year":"2021","journal-title":"Cancer Med."},{"issue":"7","key":"10.1016\/j.tranon.2024.102179_bib0002","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","article-title":"Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020","volume":"134","author":"Cao","year":"2021","journal-title":"Chin. Med. J. (Engl)"},{"issue":"2","key":"10.1016\/j.tranon.2024.102179_bib0003","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1470-2045(09)70021-X","article-title":"Preoperative treatment and surgery in gastric cancer: friends or foes","volume":"10","author":"D'Ugo","year":"2009","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2024.102179_bib0004","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3322\/caac.21657","article-title":"Current treatment and recent progress in gastric cancer","volume":"71","author":"Joshi","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"10.1016\/j.tranon.2024.102179_bib0005","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","article-title":"Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Lordick","year":"2022","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.tranon.2024.102179_bib0006","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1158\/2159-8290.CD-21-0888","article-title":"Early Tumor-Immune Microenvironmental Remodeling and Response to First-Line Fluoropyrimidine and Platinum Chemotherapy in Advanced Gastric Cancer","volume":"12","author":"Kim","year":"2022","journal-title":"Cancer Discov."},{"issue":"9","key":"10.1016\/j.tranon.2024.102179_bib0007","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1080\/10408398.2016.1263597","article-title":"Resveratrol as an anti-cancer agent: a review","volume":"58","author":"Rauf","year":"2018","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.tranon.2024.102179_bib0008","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2021.05.001","article-title":"Resveratrol for cancer therapy: challenges and future perspectives","volume":"515","author":"Ren","year":"2021","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.tranon.2024.102179_bib0009","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3390\/toxins11120731","article-title":"The Cytotoxicity Effect of Resveratrol: cell Cycle Arrest and Induced Apoptosis of Breast Cancer 4T1 Cells","volume":"11","author":"Wu","year":"2019","journal-title":"Toxins. (Basel)"},{"key":"10.1016\/j.tranon.2024.102179_bib0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1476-4598-5-45","article-title":"Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells","volume":"5","author":"Sexton","year":"2006","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.tranon.2024.102179_bib0011","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1182\/blood-2006-02-003988","article-title":"Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells","volume":"109","author":"Bhardwaj","year":"2007","journal-title":"Blood"},{"issue":"298","key":"10.1016\/j.tranon.2024.102179_bib0012","doi-asserted-by":"crossref","first-page":"298ra117","DOI":"10.1126\/scitranslmed.aaa7619","article-title":"Cancer chemoprevention: evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice","volume":"7","author":"Cai","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.tranon.2024.102179_bib0013","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13046-016-0487-8","article-title":"Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN\/Akt signaling pathway in gastric cancer","volume":"36","author":"Xu","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.tranon.2024.102179_bib0014","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.3390\/molecules27103047","article-title":"Resveratrol Decreases the Invasion Potential of Gastric Cancer Cells","volume":"27","author":"Rojo","year":"2022","journal-title":"Molecules."},{"issue":"1","key":"10.1016\/j.tranon.2024.102179_bib0015","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12935-021-01773-7","article-title":"Anti-tumor activity of resveratrol against gastric cancer: a review of recent advances with an emphasis on molecular pathways","volume":"21","author":"Ashrafizadeh","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.tranon.2024.102179_bib0016","article-title":"pH-responsive resveratrol-loaded ZIF-8 nanoparticles modified with tannic acid for promoting colon cancer cell apoptosis","author":"Sun","year":"2023","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"10.1016\/j.tranon.2024.102179_bib0017","article-title":"Potential application of resveratrol in nanocarriers against cancer: overview and future trends","volume":"53","author":"Moshawih Said","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.tranon.2024.102179_bib0018","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.msec.2015.09.068","article-title":"Antibacterial nanocarriers of resveratrol with gold and silver nanoparticles","volume":"58","author":"Park","year":"2016","journal-title":"Mater. Sci. Eng. C. Mater. Biol. Appl."},{"issue":"7","key":"10.1016\/j.tranon.2024.102179_bib0019","article-title":"Mesoporous Rod-Like Metal-Organic Framework with Optimal Tumor Targeting Properties for Enhanced Activatable Photodynamic Therapy","volume":"3","author":"Yuanbo","year":"2020","journal-title":"Adv. Therapeu."},{"issue":"9","key":"10.1016\/j.tranon.2024.102179_bib0020","first-page":"2925","article-title":"Cytotoxicity of Postmodified Zeolitic Imidazolate Framework-90 (ZIF-90) Nanocrystals: correlation between Functionality and Toxicity","volume":"22","author":"Yen","year":"2016","journal-title":"Chemistry. (Easton)"},{"issue":"3","key":"10.1016\/j.tranon.2024.102179_bib0021","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1039\/C4SC03749A","article-title":"Stimuli-responsive metal-organic frameworks gated by pillar[5]arene supramolecular switches","volume":"6","author":"Tan","year":"2015","journal-title":"Chem. Sci."},{"issue":"31","key":"10.1016\/j.tranon.2024.102179_bib0022","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1002\/smll.201500155","article-title":"Zn(2+)-Triggered Drug Release from Biocompatible Zirconium MOFs Equipped with Supramolecular Gates","volume":"11","author":"Tan","year":"2015","journal-title":"Small."},{"issue":"1","key":"10.1016\/j.tranon.2024.102179_bib0023","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1039\/C5TB01789K","article-title":"Ca(2+), pH and thermo triple-responsive mechanized Zr-based MOFs for on-command drug release in bone diseases","volume":"4","author":"Tan","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.tranon.2024.102179_bib0024","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jcis.2020.12.028","article-title":"Cu-MOF chemodynamic nanoplatform via modulating glutathione and H(2)O(2) in tumor microenvironment for amplified cancer therapy","volume":"587","author":"Tian","year":"2021","journal-title":"J. Colloid. Interface Sci."},{"key":"10.1016\/j.tranon.2024.102179_bib0025","doi-asserted-by":"crossref","first-page":"10195","DOI":"10.2147\/IJN.S230524","article-title":"Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application","volume":"14","author":"Sun","year":"2019","journal-title":"Int. J. Nanomedicine"},{"issue":"3","key":"10.1016\/j.tranon.2024.102179_bib0026","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/pharmaceutics12030232","article-title":"Metal Organic Frameworks as Drug Targeting Delivery Vehicles in the Treatment of Cancer","volume":"12","author":"Cai","year":"2020","journal-title":"Pharmaceutics."},{"issue":"1","key":"10.1016\/j.tranon.2024.102179_bib0027","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1021\/ja909263x","article-title":"Highly permeable zeolite imidazolate framework-8 membranes for CO2\/CH4 separation","volume":"132","author":"Venna","year":"2010","journal-title":"J. Am. Chem. Soc."},{"issue":"8","key":"10.1016\/j.tranon.2024.102179_bib0028","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1039\/C5CS00837A","article-title":"Zr-based metal-organic frameworks: design, synthesis, structure, and applications","volume":"45","author":"Bai","year":"2016","journal-title":"Chem. Soc. Rev."},{"issue":"48","key":"10.1016\/j.tranon.2024.102179_bib0029","doi-asserted-by":"crossref","first-page":"15507","DOI":"10.1021\/jacs.6b11821","article-title":"Reticular Chemistry-Construction, Properties, and Precision Reactions of Frameworks","volume":"138","author":"Yaghi","year":"2016","journal-title":"J. Am. Chem. Soc."},{"issue":"19","key":"10.1016\/j.tranon.2024.102179_bib0030","doi-asserted-by":"crossref","first-page":"6204","DOI":"10.1021\/jacs.6b01663","article-title":"Highly Stable Zr(IV)-Based Metal-Organic Frameworks for the Detection and Removal of Antibiotics and Organic Explosives in Water","volume":"138","author":"Wang","year":"2016","journal-title":"J. Am. Chem. Soc."},{"issue":"10","key":"10.1016\/j.tranon.2024.102179_bib0031","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1021\/jacs.6b00007","article-title":"Size-Controlled Synthesis of Porphyrinic Metal-Organic Framework and Functionalization for Targeted Photodynamic Therapy","volume":"138","author":"Park","year":"2016","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.tranon.2024.102179_bib0032","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1021\/jacs.5b11720","article-title":"One-pot Synthesis of Metal-Organic Frameworks with Encapsulated Target Molecules and Their Applications for Controlled Drug Delivery","volume":"138","author":"Zheng","year":"2016","journal-title":"J. Am. Chem. Soc."},{"issue":"8","key":"10.1016\/j.tranon.2024.102179_bib0033","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1021\/acsbiomaterials.0c00935","article-title":"Situ Biomimetic Mineralization on ZIF-8 for Smart Drug Delivery","volume":"6","author":"Shi","year":"2020","journal-title":"ACS Biomater Sci Eng."},{"issue":"16","key":"10.1016\/j.tranon.2024.102179_bib0034","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1021\/jacs.7b01229","article-title":"Mitochondria Targeted Nanoscale Zeolitic Imidazole Framework-90 for ATP Imaging in Live Cells","volume":"139","author":"Deng","year":"2017","journal-title":"J. Am. Chem. Soc."},{"issue":"16","key":"10.1016\/j.tranon.2024.102179_bib0035","doi-asserted-by":"crossref","first-page":"7869","DOI":"10.7150\/thno.59593","article-title":"ATP-triggered mitochondrial cascade reactions for cancer therapy with nanoscale zeolitic imidazole framework-90","volume":"11","author":"Pan","year":"2021","journal-title":"Theranostics."},{"issue":"12","key":"10.1016\/j.tranon.2024.102179_bib0036","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.tranon.2024.102179_bib0037","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12951-022-01441-6","article-title":"Tumor microenvironment responsive Mn(3)O(4) nanoplatform for in vivo real-time monitoring of drug resistance and photothermal\/chemodynamic synergistic therapy of gastric cancer","volume":"20","author":"Li","year":"2022","journal-title":"J. Nanobiotechnology."},{"key":"10.1016\/j.tranon.2024.102179_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115573","article-title":"Biotin decorated celastrol-loaded ZIF-8 nano-drug delivery system targeted epithelial ovarian cancer therapy","volume":"167","author":"Zhou","year":"2023","journal-title":"Biomed. PharmacOther"},{"issue":"1","key":"10.1016\/j.tranon.2024.102179_bib0039","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1021\/acsami.1c21924","article-title":"Ultrasound Microbubbles Mediated Sonosensitizer and Antibody Co-delivery for Highly Efficient Synergistic Therapy on HER2-Positive Gastric Cancer","volume":"14","author":"Sun","year":"2022","journal-title":"ACS. Appl. Mater. Interfaces."},{"key":"10.1016\/j.tranon.2024.102179_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1049279","article-title":"The management of Helicobacter pylori infection and prevention and control of gastric cancer in China","volume":"12","author":"Hu","year":"2022","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.tranon.2024.102179_bib0041","doi-asserted-by":"crossref","first-page":"11014","DOI":"10.7189\/jogh.12.11014","article-title":"Survival of gastric cancer in China from 2000 to 2022: a nationwide systematic review of hospital-based studies","volume":"12","author":"Li","year":"2022","journal-title":"J. Glob. Health"},{"issue":"24","key":"10.1016\/j.tranon.2024.102179_bib0042","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.3748\/wjg.v24.i24.2567","article-title":"Tumor heterogeneity of gastric cancer: from the perspective of tumor-initiating cell","volume":"24","author":"Gao","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.tranon.2024.102179_bib0043","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1111\/cas.14191","article-title":"Dissection of gastric cancer heterogeneity for precision oncology","volume":"110","author":"Ho","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.tranon.2024.102179_bib0044","article-title":"Intratumoral Fibrosis in Facilitating Renal Cancer Aggressiveness: underlying Mechanisms and Promising Targets","volume":"9","author":"Hu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"Pt 2","key":"10.1016\/j.tranon.2024.102179_bib0045","first-page":"136","article-title":"TGF-\u03b2 in developmental and fibrogenic EMTs","volume":"86","author":"Lee","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.tranon.2024.102179_bib0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10717544.2022.2154409","article-title":"Recent advances in drug delivery systems for targeting brain tumors","volume":"30","author":"Zhao","year":"2023","journal-title":"Drug Deliv."},{"key":"10.1016\/j.tranon.2024.102179_bib0047","article-title":"Nanoparticle drug delivery systems and their applications as targeted therapies for triple negative breast cancer","volume":"134","author":"Xiangyi","year":"2023","journal-title":"Prog. Mater. Sci."},{"issue":"10","key":"10.1016\/j.tranon.2024.102179_bib0048","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.7150\/thno.38069","article-title":"Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics","volume":"10","author":"Mi","year":"2020","journal-title":"Theranostics."},{"issue":"12","key":"10.1016\/j.tranon.2024.102179_bib0049","doi-asserted-by":"crossref","first-page":"7623","DOI":"10.1021\/acsami.5b11760","article-title":"Versatile Synthesis and Fluorescent Labeling of ZIF-90 Nanoparticles for Biomedical Applications","volume":"8","author":"Jones","year":"2016","journal-title":"ACS. Appl. Mater. Interfaces."},{"issue":"3","key":"10.1016\/j.tranon.2024.102179_bib0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41419-020-2384-5","article-title":"Iron free\" zinc oxide nanoparticles with ion-leaking properties disrupt intracellular ROS and iron homeostasis to induce ferroptosis","volume":"11","author":"Zhang","year":"2020","journal-title":"Cell Death. Dis."},{"issue":"5","key":"10.1016\/j.tranon.2024.102179_bib0051","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1021\/acsbiomaterials.3c01693","article-title":"Developing a Selection Framework for Zinc Ion-Based Biomaterial Design: guided by the Biosafety Assessment of ZIF-8 and ZnO","volume":"10","author":"Mao","year":"2024","journal-title":"ACS. Biomater. Sci. Eng."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193652332400305X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193652332400305X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T13:18:28Z","timestamp":1734700708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193652332400305X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":51,"alternative-id":["S193652332400305X"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2024.102179","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Res@ZIF-90 suppress gastric cancer progression by disturbing mitochondrial homeostasis","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2024.102179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. CCBYLICENSE","name":"copyright","label":"Copyright"}],"article-number":"102179"}}